Working on some of the most important breakthroughs in tuberculosis (TB) diagnostics globally, and testing HIV and TB vaccines, is a vital part of the pioneering work being done at the Khayelitsha-based Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa).
People living with HIV who are hospitalized at the time tuberculosis is diagnosed are at high risk of death, even after starting antituberculosis treatment. Charlotte Schutz and members of the CIDRI-Africa team studied a group of patients to find out why.
A £300 award is available for third year special study module (SSM) students who undertake their research projects in the Division of Endocrinology.
Dr Ying Zhao’s MMed study is entitled “Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis”. Her MMed is supervised by Dr Sean Wasserman and Professor Graeme Meintjes.